PVG Asset Management’s Novo Nordisk NVO Stock Holding History

PVG Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$260K	Buy	+8,648	New	+$257K	0.62%	34

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

PVG Asset Management's NVO Position: Q1 2020 in Review

PVG Asset Management opened a new position in Novo Nordisk (NVO) in Q1 2020: 8,648 shares worth $260K. The stake represents 0.62% of the portfolio and ranks #34 among its holdings.

644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.

PVG Asset Management held 8,648 shares of Novo Nordisk worth $260K as of Q1 2020.
Novo Nordisk was a new PVG Asset Management position in Q1 2020.
Novo Nordisk made up 0.62% of PVG Asset Management's portfolio in Q1 2020, its #34 holding.
644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.

Based on PVG Asset Management's 13F filing for Q1 2020, filed 15 May 2020.